Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines.
BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) remains one of the most deadly cancers in Europe and the USA. There is consensus that radical tumor surgery is the only viable option for any long-term survival in patients with PDAC. So far, limited data are available regarding the routine surgical...
Main Authors: | Sameer A Dhayat, Philip Mirgorod, Christina Lenschow, Norbert Senninger, Christoph Anthoni, Thorsten Vowinkel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5340358?pdf=render |
Similar Items
-
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
by: Sameer Abdallah Dhayat, et al.
Published: (2018-09-01) -
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma.
by: Sameer A Dhayat, et al.
Published: (2015-01-01) -
Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.
by: Sameer A Dhayat, et al.
Published: (2021-01-01) -
Potential of Exosomal microRNA-200b as Liquid Biopsy Marker in Pancreatic Ductal Adenocarcinoma
by: Moritz Reese, et al.
Published: (2020-01-01) -
Current and future biomarkers for pancreatic adenocarcinoma
by: Sven H Loosen, et al.
Published: (2017-05-01)